Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Next Week Could Be Big for Johnson & Johnson: Analyst
Barron's
Friday, September 2, 2011 - 12:13pm
tags:
JNJ, bloodthinners, Xarelto
Sanofi: We'll sell generic Lipitor in France
Yahoo/AP
Friday, September 2, 2011 - 12:11pm
tags:
Lipitor, generics, Sanofi, France, Pfizer, statins
Baxter sues Teva over propofol liability suits
Fierce Pharma
Thursday, September 1, 2011 - 12:38pm
tags:
Baxter, propofol, Teva Pharmaceuticals, lawsuits
Bain, 2 drugmakers still in race for GSK consumer portfolio
Fierce Pharma
Thursday, September 1, 2011 - 12:19pm
tags:
Bain Capital, GSK, OTC
The Big Bet on YM BioSciences
Motley Fool
Thursday, September 1, 2011 - 12:11pm
tags:
YM BioSciences, myelofibrosis, ruxolitinib, CYT387, Novartis, Incyte
4 Leading Medical Stocks With A Healthy Future
Seeking Alpha
Thursday, September 1, 2011 - 12:10pm
tags:
Mako Surgical, Athenahealth, Jazz Pharmaceuticals, Questcor
Selecta lands malaria vaccine deal, names new CSO
Bizjournals.com
Thursday, September 1, 2011 - 12:06pm
tags:
Selecta, malaria
Shire Enters a Crowded Market
Motley Fool
Thursday, September 1, 2011 - 11:37am
tags:
Shire, Firazyr, Dyax, angioedema, CSL
Biotech Busts And Breakthroughs For August
Forbes
Thursday, September 1, 2011 - 11:34am
tags:
Mako Surgical, Luminex, Regeneron, Pharmasset, ViroPharma, Dendreon, Pacific Biosciences, ZOLL Medical, Savient, Human Genome Sciences
Authorized Generics Are A Double Whammy: FTC
Pharmalot
Thursday, September 1, 2011 - 11:32am
tags:
authorized generics, FTC
CoLucid Pharmaceuticals raises $4M
Bizjournals.com
Thursday, September 1, 2011 - 11:29am
tags:
Colucid Pharmceuticals, fundraising
Xoma CEO Steps Down After Four Years
Minyanville
Thursday, September 1, 2011 - 11:28am
tags:
Xoma, Pharma CEOs
Analyzing 5 High Yield Healthcare Stocks For Buy Opportunities
Seeking Alpha
Thursday, September 1, 2011 - 11:28am
tags:
Eli Lilly, GSK, AstraZeneca, PDL Biopharma, Sanofi
Pfizer Extends Tender Offer to Acquire Icagen, Inc.
Yahoo
Thursday, September 1, 2011 - 9:04am
tags:
Pfizer, M&A, Icagen, tender offer
FDA, Brand Drug Firms Agree on Increased Fees
WSJ Online
Thursday, September 1, 2011 - 8:28am
tags:
FDA
Teva Pharmaceuticals: Time To Buy
Seeking Alpha
Thursday, September 1, 2011 - 8:06am
tags:
Teva Pharmaceuticals
Impax Labs faces suit by Avanir Pharma after challenging patents on its drug Nuedexta
Yahoo/AP
Thursday, September 1, 2011 - 8:05am
tags:
patents, Avanir, Nuedexta, PBA, Impax Labs
Sanofi Has Lipitor Generic Accord With Pfizer, Echos Says
Bloomberg
Thursday, September 1, 2011 - 8:04am
tags:
Lipitor, Pfizer, generics, Sanofi
2 Healthcare Companies Expecting September Catalysts
Seeking Alpha
Thursday, September 1, 2011 - 8:03am
tags:
Amarin, AMR101, Iluvien, Alimera
Horizon Pharma turns $11.6M loss in 2nd quarter
Yahoo/AP
Wednesday, August 31, 2011 - 2:20pm
tags:
earnings, Horizon Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.